Tissue-specific regulation of ACE/ACE2 and AT1/AT2 receptor gene expression by oestrogen in apolipoprotein E/oestrogen receptor-α knock-out mice

Experimental Physiology

Volumn 93, Issue 5, 2008, Pages 658-664

  Brosnihan, K Bridget ^a   Hodgin, Jeffrey B ^b   Smithies, Oliver ^b   Maeda, Nobuyo ^b   Gallagher, Patricia ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; APOLIPOPROTEIN E; DIPEPTIDYL CARBOXYPEPTIDASE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; FEMALE; GENE EXPRESSION; MOUSE; NONHUMAN; PROTEIN FOLDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SPECIFICITY; UPREGULATION;

EID: 42649135572     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2007.041806     Document Type: Article

References (31)

1. Armando I, Jezova M, Juorio A, Terrón JA, Falcón‐Neri A, Semino‐Mora C, Imboden H & Saavedra JM (2002). Estrogen upregulates renal angiotensin II AT 2 receptors. Am J Physiol Renal Physiol 283, F934–F943.
2. Baiardi G, Macova M, Armando I, Ando H, Tyurmin D & Saavedra JM (2005). Estrogen upregulates renal angiotensin II AT1 and AT2 receptors in the rat. Regul Pept 124, 7–17.
3. Brosnihan KB, Li P & Gallagher PE (2000). Down regulation of angiotensin converting enzyme mRNA by estrogen. Menopause Digest 2, 22–23.
4. Brosnihan KB, Senanayake PS, Li P & Ferrario CM (1999). Bi‐directional actions of estrogen on the renin‐angiotensin system. Braz J Med Biol Res 32, 373–381.
5. Burrell LM, Johnston CI, Tikellis C & Cooper ME (2004). ACE2, a new regulator of the renin‐angiotensin system. Trends Endocrinol Metab 15, 166–169.
6. Clarkson TB, Anthony MS & Klein KP (1996). Hormone replacement therapy and coronary artery atherosclerosis: the monkey model. Br J Obstet Gynaecol 103 (Suppl. 13), 53–57 ; discussion 57–58.
7. Clarkson TB, Prichard RW, Morgan TM, Petrick GS & Klein KP (1994). Remodeling of coronary arteries in human and nonhuman primates. JAMA 271, 289–294.
8. Couse JF, Curtis SW, Washburn TF, Lindzey J, Golding TS, Lubahn DB, Smithies O & Korach KS (1995). Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol Endocrinol 9, 1441–1454.
9. Gallagher PE, Chappell MC, Ferrario CM & Tallant EA (2006). Distinct roles for ANG II and ANG‐(1–7) in the regulation of angiotensin‐converting enzyme 2 in rat astrocytes. Am J Physiol Heart Circ Physiol 290, 420–426.
10. Gallagher PE, Li P, Lenhart JR, Chappell MC & Brosnihan KB (1999). Estrogen regulation of angiotensin‐converting enzyme mRNA. Hypertension 33, 323–328.
11. Gembardt F, Sterner‐Kock A, Imboden H, Spalteholz M, Reibitz F, Schultheiss HP, Siems WE & Walther T (2005). Organ‐specific distribution of ACE2 mRNA and correlating peptidase activity in rodents. Peptides 26, 1270–1277.
12. Goraya TY, Kessler SP, Kumar RS, Douglas J & Sen GC (1994). Identification of positive and negative transcriptional regulatory elements of the rabbit angiotensin‐converting enzyme gene. Nuclei Acids Res 22, 1194–1201.
13. Goulter AB, Goddard MJ, Allen JC & Clark KL (2004). ACE2 gene expression is up‐regulated in the human failing heart. BMC Med 2, 19–26.
14. Hodgin JB, Krege JH, Reddick RL, Korach KS, Smithies O & Maeda N (2001). Estrogen receptor is a major mediator of 17β‐estradiol's atheroprotective effects on lesion size in Apoe −/− mice. J Clin Invest 107, 333–340.
15. Howard T, Balogh R, Overbeek P & Bernstein KE (1993). Sperm‐specific expression of angiotensin‐converting enzyme (ACE) is mediated by a 91‐base‐pair promoter containing a CRE‐like element. Mol Cell Biol 13, 18–27.
16. Ichiki T & Inagami T (1995). Expression, genomic organization, and transcription of the mouse angiotensin II type 2 receptor gene. Circ Res 76, 693–700.
17. Ji H, Pesce C, Menini S, Wu X, Zheng W & Sandberg K (2007). 17β‐Estradiol (E2)‐mediated protection from renal injury is associated with angiotensin converting enzyme 2 (ACE2) up regulation. Hypertension 48, e28.
18. Joyner J, Neves LA, Granger JP, Alexander BT, Merrill DC, Chappell MC, Ferrario CM, Davis WP & Brosnihan KB (2007). Temporal‐spatial expression of angiotensin‐(1–7) and angiotensin converting enzyme 2 in the kidney of normal and hypertensive pregnant rats. Am J Physiol Regul Integr Comp Physiol 239, R169–R177.
19. Kakuchi J, Ichiki T, Kiyama S, Hogan BL, Fogo A, Inagami T & Ichikawa I (1995). Developmental expression of renal angiotensin II receptor genes in the mouse. Kidney Int 47, 140–147.
20. Keidar S, Gamliel‐Lazarovich A, Kaplan M, Pavlotzky E, Hamoud S, Hayek T, Karry R & Abassi Z (2005). Mineralocorticoid receptor blocker increases angiotensin‐converting enzyme 2 activity in congestive heart failure patients. Circ Res 97, 946–953.
21. Krishnamurthi K, Verbalis JG, Zheng W, Wu Z, Clerch LB & Sandberg K (1999). Estrogen regulates angiotensin AT1 receptor expression via cytosolic proteins that bind to the 5′ leader sequence of the receptor mRNA. Endocrinology 140, 5435–5438.
22. Lefebvre F, Prefontaine A, Calderone A, Caron A, Jasmin JF, Villeneuve L & Dupuis J (2006). Modification of the pulmonary renin‐angiotensin system and lung structural remodelling in congestive heart failure. Clin Sci (Lond) 111, 217–224.
23. Nasjletti A, Matsunaga M & Masson GMC (1969). Effects of estrogens on plasma angiotensinogen and renin activity in nephrectomized rats. Endocrinology 85, 967–970.
24. Neves LAA, Stovall K, Joyner J, Valdés G, Gallagher PE, Ferrario CM, Merrill DC & Brosnihan KB (2008). ACE2 and ANG‐(1–7) in the uterus during early and late gestation. Am J Physiol Regul Integr Comp Physiol 294, R151–R161.
25. Nickenig G, Bäumer AT, Grohè C, Kahlert S, Strehlow K, Rosenkranz S, Stäblein A, Beckers F, Smits JF, Daemen MJ, Vetter H & Böhm M (1998). Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation 97, 2197–2201.
26. Ojeda NB, Grigore D, Robertson EB & Alexander BT (2007). Estrogen protects against increased blood pressure in postpubertal female growth restricted offspring. Hypertension 50, 679–685.
27. Proudler AJ, Cooper A, Whitehead M & Stevenson JC (2003). Effects of oestrogen‐only and oestrogen‐progestogen replacement therapy upon circulating angiotensin I‐converting enzyme activity in postmenopausal women. Clin Endocrinol (Oxf) 58, 30–35.
28. Riviere G, Michaud A, Breton C, Vancamp G, Laborie C, Enache M, Lesage J, DeLoof S, Corvol P & Vieau D (2005). Angiotensin‐converting enzyme 2 (ACE2) and ACE activities display tissue‐specific sensitivity to undernutrition‐programmed hypertension in the adult rat. Hypertension 46, 1169–1174.
29. Seely EW, Brosnihan KB, Jeunemaitre X, Okamura K, Williams GH, Hollenberg NK & Herrington DM (2004). Effects of conjugated oestrogen and droloxifene on the renin‐angiotensin system, blood pressure and renal blood flow in postmenopausal women. Clin Endocrinol 60, 315–321.
30. Shaltout H, Westwood B, Averill DB, Ferrario CM, Figueroa J, Diz DI & Chappell MC (2007). Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2‐dependent processing of angiotensin II. Am J Physiol Regul Integr Comp Physiol 292, F82–F91.
31. Wu Z, Zheng W & Sandberg K (2003). Estrogen regulates adrenal angiotensin type 1 receptors by modulating adrenal angiotensin levels. Endocrinology 144, 1350–1356.